Related references
Note: Only part of the references are listed.Roles for KRAS in Pancreatic Tumor Development and Progression
Marina Pasca di Magliano et al.
GASTROENTEROLOGY (2013)
Genetically engineered mouse models of pancreatic adenocarcinoma
Carmen Guerra et al.
MOLECULAR ONCOLOGY (2013)
Identification of tumorigenic and therapeutically actionable mutations in transplantable mouse tumor cells by exome sequencing
J. Bhadury et al.
ONCOGENESIS (2013)
Pathology and Molecular Genetics of Pancreatic Neoplasms
Laura D. Wood et al.
CANCER JOURNAL (2012)
Genomic Sequencing of Key Genes in Mouse Pancreatic Cancer Cells
Y. Wang et al.
CURRENT MOLECULAR MEDICINE (2012)
Mucin (Muc) expression during pancreatic cancer progression in spontaneous mouse model: potential implications for diagnosis and therapy
Satyanarayana Rachagani et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2012)
Mouse models of pancreatic cancer
Marta Herreros-Villanueva et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2012)
Management strategies in pancreatic cancer
Christopher J. Campen et al.
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2011)
Overcoming drug resistance in pancreatic cancer
Jiang Long et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2011)
FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
Thierry Conroy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Effects of Thymoquinone in the Expression of Mucin 4 in Pancreatic Cancer Cells: Implications for the Development of Novel Cancer Therapies
Maria P. Torres et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Epithelial to Mesenchymal Transition Contributes to Drug Resistance in Pancreatic Cancer
Thiruvengadam Arumugam et al.
CANCER RESEARCH (2009)
Gemcitabine-Based Chemogene Therapy for Pancreatic Cancer Using Ad-dCK::UMK GDEPT and TS/RR siRNA Strategies
Soukaina Regiba et al.
NEOPLASIA (2009)
MUC4, a Multifunctional Transmembrane Glycoprotein, Induces Oncogenic Transformation of NIH3T3 Mouse Fibroblast Cells
Sangeeta Bafna et al.
CANCER RESEARCH (2008)
Development and characterization of gemcitabine-resistant pancreatic tumor cells
Ami N. Shah et al.
ANNALS OF SURGICAL ONCOLOGY (2007)
Human MUC4 mucin induces ultra-structural changes and tumorigenicity in pancreatic cancer cells
N. Moniaux et al.
BRITISH JOURNAL OF CANCER (2007)
Using genetically engineered mouse models of cancer to aid drug development: An industry perspective
Mallika Singh et al.
CLINICAL CANCER RESEARCH (2006)
Trp53R172H and KraSG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice
SR Hingorani et al.
CANCER CELL (2005)
Inhibition of MUC4 expression suppresses pancreatic tumor cell growth and metastasis
AP Singh et al.
CANCER RESEARCH (2004)
Mucins in cancer: Protection and control of the cell surface
MA Hollingsworth et al.
NATURE REVIEWS CANCER (2004)
Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse
SR Hingorani et al.
CANCER CELL (2003)
Pancreatic cancer biology and genetics
N Bardeesy et al.
NATURE REVIEWS CANCER (2002)
Share Paper
